New research redefines functional high-risk multiple myeloma in era of modern therapies
July 20, 2026
July 20, 2026
BIRMINGHAM, Alabama, July 20 -- The University of Alabama issued the following news:
* * *
New research redefines functional high-risk multiple myeloma in era of modern therapies
*
Gayathri Ravi, M.D. A new study led by researchers at the University of Alabama at Birmingham has found that patients with multiple myeloma whose disease returns within three years of receiving current intensive standard treatment should be considered functional high . . .
* * *
New research redefines functional high-risk multiple myeloma in era of modern therapies
*
Gayathri Ravi, M.D. A new study led by researchers at the University of Alabama at Birmingham has found that patients with multiple myeloma whose disease returns within three years of receiving current intensive standard treatment should be considered functional high . . .